RxDoctor Payments Data

Cathy Collier, APRN

Nurse Practitioner · Louisville, KYNPI 1083886907

Payments from drug & device makers

$3,425in general payments, 2019–2025

Across 173 payments — averaging $19.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
  • Pfizer$297
  • Lexicon Pharmaceuticals, Inc.$297
  • Boehringer Ingelheim$214
  • Johnson & Johnson$195
  • E.r. Squibb & Sons, L.L.C.$166
  • plus $1K from 18 others

What the payments were for

  • Food & beverage$3,425100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,425 in reported general payments places this provider in the 85th percentile of 1,918 nurse practitioner providers in Kentucky.

See all nurse practitioner providers in Kentucky

Medicare billing

Part B allowed, 2024
$3,563
Medicare patients
93
Services billed
183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban33$24,319
BrilintaTicagrelor18$8,804
Metoprolol Succinate57$557
Isosorbide Dinitrate16$395
Losartan Potassium35$309
Atorvastatin Calcium50$287
Amiodarone Hcl15$202
Hydralazine Hcl19$200
Isosorbide Mononitrate ErIsosorbide Mononitrate20$151
Metoprolol Tartrate37$94
Furosemide37$70
Spironolactone16$53
ClopidogrelClopidogrel Bisulfate16$48
Carvedilol11$28
Amlodipine Besylate20$26

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$297$24,31933 claims
AstraZenecaBrilinta$150$8,80418 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,918 nurse practitioner providers in Kentucky.

Other nurse practitioner in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →